We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Ananda Developments PLC (ANA) ORD GBP0.002

Sell:0.30p Buy:0.35p Change: 0.005p (1.54%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:0.30p
Buy:0.35p
Change: 0.005p (1.54%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:0.30p
Buy:0.35p
Change: 0.005p (1.54%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Ananda Developments Plc is a United Kingdom-based medical cannabis company. The Company is a provider of medical cannabis for the treatment of complex, chronic inflammatory pain conditions in the United Kingdom (UK) and international markets. The Company is engaged in creating United Kingdom-based operations to grow and provide carbon-zero, consistent medical cannabis. The Company focuses its investments on companies or projects that are conducting research into the potential of cannabis and its active ingredients to be developed as pharmaceuticals or related products, including nutraceuticals, dietary supplements, and cosmetic products.

Contact details

Address:
6th Fl
Allianz House, 60 Gracechurch Street
LONDON
EC3V 0HR
United Kingdom
Telephone:
+ (0)
Website:
https://anandadevelopments.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

EPIC:
ANA
ISIN:
GB00BDQPXQ60
Market cap:
£9.34 million
Shares in issue:
2.87 billion
Sector:
Pharmaceuticals
Exchange:
-
Currency:
Sterling pence
Indices:
n/a

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.